Literature DB >> 11212337

Bacterial antibiotic efflux systems of medical importance.

T Köhler1, J C Pechère, P Plésiat.   

Abstract

Multidrug efflux systems endow on bacterial cells the ability to limit the access of antimicrobial agents to their targets. By actively pumping out antibiotic molecules, these systems prevent the intracellular accumulation necessary for antibiotics to exert their lethal activity. Drug efflux appears to be one of the most widespread antibiotic resistance mechanisms among microorganisms, since it has been demonstrated to occur in many Gram-positive and Gram-negative bacteria including medically important species like staphylococci, streptococci, enterobacteria and opportunistic pathogens like Pseudomonas aeruginosa. Efflux pumps can be specific for only one substrate or accommodate a more or less wide range of noxious products. Export of structurally unrelated compounds confers a multidrug-resistance phenotype on bacterial cells. Therapeutically critical levels of resistance can be achieved by overexpression of efflux systems, especially in those species such as P. aeruginosa which possess a low outer membrane permeability. It is suspected that the dual physiological function of active efflux systems is both the secretion of intracellular metabolites and the protection against a variety of harmful substances that the microorganism may encounter in its natural environment.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 11212337     DOI: 10.1007/s000180050024

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  10 in total

1.  Evidence for multiple-antibiotic resistance in Campylobacter jejuni not mediated by CmeB or CmeF.

Authors:  Lilian Pumbwe; Luke P Randall; Martin J Woodward; Laura J V Piddock
Journal:  Antimicrob Agents Chemother       Date:  2005-04       Impact factor: 5.191

2.  Inhibition of antibiotic efflux in bacteria by the novel multidrug resistance inhibitors biricodar (VX-710) and timcodar (VX-853).

Authors:  Steve Mullin; Nagraj Mani; Trudy H Grossman
Journal:  Antimicrob Agents Chemother       Date:  2004-11       Impact factor: 5.191

3.  Characterization of inhibitor-resistant histone deacetylase activity in plant-pathogenic fungi.

Authors:  Dipnath Baidyaroy; Gerald Brosch; Stefan Graessle; Patrick Trojer; Jonathan D Walton
Journal:  Eukaryot Cell       Date:  2002-08

4.  Chemical composition and antibacterial activity of essential oils of Eugenia species.

Authors:  Michele D A Magina; Eduardo M Dalmarco; Alberto Wisniewski; Edesio L Simionatto; Juliana B Dalmarco; Moacir G Pizzolatti; Inês M C Brighente
Journal:  J Nat Med       Date:  2009-03-24       Impact factor: 2.343

5.  Rotating antibiotics in the intensive care unit: feasible, apparently beneficial, but questions remain.

Authors:  Jean-Claude Pechère
Journal:  Crit Care       Date:  2002-01-11       Impact factor: 9.097

6.  Menadione (vitamin K) enhances the antibiotic activity of drugs by cell membrane permeabilization mechanism.

Authors:  Jacqueline C Andrade; Maria Flaviana B Morais Braga; Gláucia Morgana M Guedes; Saulo R Tintino; Maria A Freitas; Lucindo J Quintans; Irwin R A Menezes; Henrique D M Coutinho
Journal:  Saudi J Biol Sci       Date:  2015-10-21       Impact factor: 4.219

7.  Structural, Biochemical, and In Vivo Characterization of MtrR-Mediated Resistance to Innate Antimicrobials by the Human Pathogen Neisseria gonorrhoeae.

Authors:  Grace A Beggs; Yaramah M Zalucki; Muthiah Kumaraswami; Nicholas Gene Brown; Sheila Rastegari; Rebecca K Phillips; Timothy Palzkill; William M Shafer; Richard G Brennan
Journal:  J Bacteriol       Date:  2019-09-20       Impact factor: 3.490

8.  Structural and biochemical characterization of MepR, a multidrug binding transcription regulator of the Staphylococcus aureus multidrug efflux pump MepA.

Authors:  Muthiah Kumaraswami; Jason T Schuman; Susan M Seo; Glenn W Kaatz; Richard G Brennan
Journal:  Nucleic Acids Res       Date:  2009-01-07       Impact factor: 16.971

9.  The molecular mechanisms of allosteric mutations impairing MepR repressor function in multidrug-resistant strains of Staphylococcus aureus.

Authors:  Ivan Birukou; Nam K Tonthat; Susan M Seo; Bryan D Schindler; Glenn W Kaatz; Richard G Brennan
Journal:  MBio       Date:  2013-08-27       Impact factor: 7.867

Review 10.  Recent Advances in Multi-Drug Resistance (MDR) Efflux Pump Inhibitors of Gram-Positive Bacteria S. aureus.

Authors:  Jadwiga Handzlik; Anna Matys; Katarzyna Kieć-Kononowicz
Journal:  Antibiotics (Basel)       Date:  2013-02-05
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.